Nasdaq · Healthcare
ICU MEDICAL INC/DE (ICUI)
As-reported financials and recent SEC filings for ICU MEDICAL INC/DE, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$2.23B
Net income
$732,000
Net margin
0.0%
Diluted EPS
$0.03
ROE
0.0%
P/E (TTM)
80.1×
Market cap
$3.71B
Debt / equity
0.6×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.23B | $2.38B | $2.26B | $2.28B | $1.32B |
| Gross profit | $822.0M | $824.8M | $739.9M | $697.8M | $491.5M |
| Operating income | $42.8M | $43.0M | $22.8M | $-42.9M | $123.2M |
| Net income | $732,000 | $-117.7M | $-29.7M | $-74.3M | $103.1M |
| Diluted EPS | $0.03 | $-4.83 | $-1.23 | $-3.11 | $4.74 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
SD2026-06-01
View on EDGAR →1442026-05-22
View on EDGAR →42026-05-22
View on EDGAR →8-K2026-05-18
View on EDGAR →42026-05-15
View on EDGAR →1442026-05-14
View on EDGAR →SCHEDULE 13G/A2026-05-13
View on EDGAR →42026-05-13
View on EDGAR →Go deeper on ICUI
Search ICU MEDICAL INC/DE’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.